Varex Imaging (NASDAQ:VREX) Issues Earnings Results

Key Points

• Varex Imaging beat earnings expectations: Quarterly EPS was $0.31, exceeding the $0.21 consensus estimate by $0.10. Revenue totaled $210.5 million, falling short of the $215.5 million forecast.
• The stock opened at $12.41, with a market capitalization of approximately $522.5 million. Varex reported an 8.19% return on equity but continued to post a negative net margin of 9.64%.
• Analyst sentiment remains mixed, with two Buy, two Hold and one Sell rating; the consensus rating is Hold, with a target price of $16.17.

Varex Imaging (NASDAQ:VREX - Get Free Report) released its earnings results on Monday. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.21 by $0.10, FiscalAI reports. Varex Imaging had a positive return on equity of 8.19% and a negative net margin of 9.64%.The firm had revenue of $210.50 million during the quarter, compared to analysts' expectations of $215.50 million.

Varex Imaging Price Performance

NASDAQ:VREX opened at $12.41 on Monday. The stock has a market capitalization of $522.46 million, a PE ratio of -6.21 and a beta of 0.89. Varex Imaging has a 1-year low of $8.42 and a 1-year high of $14.56. The firm has a fifty day simple moving average of $10.77 and a 200 day simple moving average of $11.51. The company has a current ratio of 3.20, a quick ratio of 1.43 and a debt-to-equity ratio of 0.67.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Zacks Research downgraded Varex Imaging from a "strong-buy" rating to a "hold" rating in a report on Monday, July 27th. Wall Street Zen upgraded Varex Imaging from a "hold" rating to a "buy" rating in a research note on Saturday, July 4th. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Varex Imaging in a research report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Varex Imaging has an average rating of "Hold" and a consensus target price of $16.17.

Institutional Trading of Varex Imaging

A number of large investors have recently added to or reduced their stakes in VREX. Mariner LLC acquired a new stake in shares of Varex Imaging in the fourth quarter valued at approximately $174,000. Cerity Partners LLC increased its holdings in shares of Varex Imaging by 30.2% during the 4th quarter. Cerity Partners LLC now owns 17,135 shares of the company's stock worth $200,000 after acquiring an additional 3,979 shares during the last quarter. Brooklyn Investment Group increased its holdings in shares of Varex Imaging by 51.3% during the 3rd quarter. Brooklyn Investment Group now owns 17,511 shares of the company's stock worth $217,000 after acquiring an additional 5,934 shares during the last quarter. Glenmede Investment Management LP acquired a new position in shares of Varex Imaging during the 3rd quarter worth approximately $153,000. Finally, Inceptionr LLC bought a new stake in Varex Imaging in the 3rd quarter valued at $152,000.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company's medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source